Ensign Peak Advisors »

Alnylam Pharmaceuticals shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $11M 59k 177.10
2023-06-30 $9.0M 47k 189.94
2023-03-31 $7.9M 40k 200.32
2022-12-31 $8.8M 37k 237.65
2022-09-30 $7.1M 36k 200.14
2022-06-30 $5.4M 37k 145.83
2022-03-31 $5.9M 36k 163.27
2021-12-31 $6.9M 41k 169.60
2021-09-30 $32M 169k 188.81
2021-06-30 $29M 173k 169.52
2021-03-31 $24M 168k 141.19
2020-12-31 $14M 110k 129.96
2020-09-30 $17M 113k 145.60
2020-06-30 $11M 76k 148.10
2020-03-31 $4.3M 40k 108.87
2019-12-31 $540k 4.7k 115.11